PLPL
Plandaí Biotechnology, Inc.
Price Chart
Latest Quote
$0.00
+0.00 (+0.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 773,640 |
Stock Information
| Shares Outstanding | 44.89B |
| Total Debt | $16.83M |
| Cash Equivalents | $22K |
| Revenue | $338K |
| Net Income | $-4.32M |
| Sector | Industrials |
| Industry | Specialty Business Services |
| Market Cap | $449K |
| Exchange | OID |
📊 Comprehensive Analysis
Company Data
| Enterprise Value | $14.54M |
| Sales | $338K |
| Income | $-4.32M |
| Book/sh | $-0.04 |
| Cash/sh | $0.00 |
| Employees | 180 |
Financial Ratios
| Quick Ratio | 0.00 |
| Current Ratio | 0.01 |
Returns & Margins
| ROA | -26.23% |
| Gross Margin | -168.10% |
| Operating Margin | -889.87% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/S | 1.33 |
| P/B | -0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | nan |
| Volatility | 28.05 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | -90.00% |
| 6 Months | -90.00% |
| YTD | -90.00% |
| Year | -80.00% |
| 3 Years | -98.46% |
| 5 Years | -98.75% |
| 10 Years | -99.97% |
Stock Score:
⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature
Sign up for free to view detailed scoring breakdown — premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.00 | 0 |
| 2026-06-17 | $0.00 | 0 |
| 2026-06-16 | $0.00 | 0 |
| 2026-06-15 | $0.00 | 0 |
| 2026-06-12 | $0.00 | 0 |
| 2026-06-11 | $0.00 | 0 |
| 2026-06-10 | $0.00 | 0 |
| 2026-06-09 | $0.00 | 0 |
| 2026-06-08 | $0.00 | 0 |
| 2026-06-05 | $0.00 | 0 |
| 2026-06-04 | $0.00 | 0 |
| 2026-06-03 | $0.00 | 0 |
| 2026-06-02 | $0.00 | 0 |
| 2026-06-01 | $0.00 | 0 |
| 2026-05-29 | $0.00 | 0 |
| 2026-05-28 | $0.00 | 0 |
| 2026-05-27 | $0.00 | 0 |
| 2026-05-26 | $0.00 | 0 |
| 2026-05-22 | $0.00 | 0 |
| 2026-05-21 | $0.00 | 0 |
| 2026-05-20 | $0.00 | 0 |
| 2026-05-19 | $0.00 | 0 |
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. does not have significant operations. Previously, it was involved in a biotechnology-related business. Plandaí Biotechnology, Inc. is based in Taipei, Taiwan.
📰 Latest News
No news articles available at the moment. Check back later for updates on PLPL.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-06-30 | 2022-06-30 |
|---|---|---|
| Revenue | ||
| Reconciled Cost Of Revenue | $0 | $0 |
| Cost Of Revenue | $0 | $0 |
| Total Revenue | $0 | $0 |
| Operating Revenue | $0 | $0 |
| Expenses | ||
| Interest Expense | $28,204 | $116,719 |
| Total Expenses | $705,501 | $24,273 |
| Other Income Expense | $-19,067,055 | $6,964,996 |
| Net Non Operating Interest Income Expense | $-28,204 | $-116,719 |
| Interest Expense Non Operating | $28,204 | $116,719 |
| Operating Expense | $705,501 | $24,273 |
| General And Administrative Expense | $705,501 | $24,273 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $-19,800,760 | $6,824,004 |
| Net Interest Income | $-28,204 | $-116,719 |
| Normalized Income | $-733,705 | $1,252,007 |
| Net Income From Continuing And Discontinued Operation | $-19,800,760 | $6,824,004 |
| Total Operating Income As Reported | $-705,501 | $-24,273 |
| Net Income Common Stockholders | $-19,800,760 | $6,824,004 |
| Net Income | $-19,800,760 | $6,824,004 |
| Net Income Including Noncontrolling Interests | $-19,800,760 | $6,824,004 |
| Net Income Continuous Operations | $-19,800,760 | $6,824,004 |
| Pretax Income | $-19,800,760 | $6,824,004 |
| Special Income Charges | $-19,625,169 | $7,968,060 |
| Operating Income | $-705,501 | $-24,273 |
| Gross Profit | $0 | $0 |
| Per Share | ||
| Diluted EPS | $-0.00 | $0.00 |
| Basic EPS | $-0.00 | $0.00 |
| Other | ||
| Tax Effect Of Unusual Items | $0 | $1,392,999 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-705,501 | $-24,273 |
| Total Unusual Items | $-19,067,055 | $6,964,996 |
| Total Unusual Items Excluding Goodwill | $-19,067,055 | $6,964,996 |
| EBITDA (Bullshit earnings) | $-19,772,556 | $6,940,723 |
| EBIT | $-19,772,556 | $6,940,723 |
| Diluted Average Shares | $7,569,871,012 | $7,059,620,332 |
| Basic Average Shares | $7,547,550,883 | $6,365,790,615 |
| Diluted NI Availto Com Stockholders | $-19,800,760 | $6,824,004 |
| Minority Interests | $0 | $0 |
| Restructuring And Mergern Acquisition | $19,625,169 | $0 |
| Gain On Sale Of Security | $558,114 | $-1,003,064 |
| Selling General And Administration | $705,501 | $24,273 |
| Other Gand A | $705,501 | $24,273 |
| Other Special Charges | - | $-7,968,060 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-06-30 | 2022-06-30 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $-442,644 | $-1,526,391 |
| Total Assets | $0 | $0 |
| Total Non Current Assets | $0 | $0 |
| Current Assets | $0 | $0 |
| Cash Cash Equivalents And Short Term Investments | $0 | $0 |
| Cash And Cash Equivalents | $0 | $0 |
| Cash Financial | $0 | $0 |
| Debt | ||
| Net Debt | $50,175 | $114,963 |
| Total Debt | $50,175 | $114,963 |
| Current Debt And Capital Lease Obligation | $50,175 | $114,963 |
| Current Debt | $50,175 | $114,963 |
| Other Current Borrowings | $50,175 | $114,963 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $442,644 | $1,526,391 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 |
| Current Liabilities | $442,644 | $1,526,391 |
| Other Current Liabilities | $7,890 | $1,003,802 |
| Payables And Accrued Expenses | $384,579 | $407,626 |
| Interest Payable | $54,334 | $111,873 |
| Payables | $330,245 | $295,753 |
| Accounts Payable | $330,245 | $295,753 |
| Equity | ||
| Common Stock Equity | $-442,654 | $-1,526,401 |
| Preferred Stock Equity | $10 | $10 |
| Total Equity Gross Minority Interest | $-442,644 | $-1,526,391 |
| Stockholders Equity | $-442,644 | $-1,526,391 |
| Other Equity Interest | $4,095,208 | - |
| Retained Earnings | $-60,047,229 | $-40,246,059 |
| Other | ||
| Ordinary Shares Number | $8,199,034,371 | $7,006,411,205 |
| Share Issued | $8,199,034,371 | $7,006,411,205 |
| Tangible Book Value | $-442,654 | $-1,526,401 |
| Invested Capital | $-392,479 | $-1,411,438 |
| Working Capital | $-442,644 | $-1,526,391 |
| Total Capitalization | $-442,644 | $-1,526,391 |
| Additional Paid In Capital | $54,689,464 | $38,019,018 |
| Capital Stock | $819,913 | $700,650 |
| Common Stock | $819,903 | $700,640 |
| Preferred Stock | $10 | $10 |
| Current Accrued Expenses | $54,334 | $111,873 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-06-30 | 2022-06-30 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $0 | $0 |
| Operating Activities | ||
| Operating Cash Flow | $0 | $0 |
| Cash Flow From Continuing Operating Activities | $0 | $0 |
| Operating Gains Losses | $-558,114 | $-6,964,996 |
| Investing Activities | ||
| Investing Cash Flow | $0 | $0 |
| Financing Activities | ||
| Financing Cash Flow | $0 | $0 |
| Other | ||
| Interest Paid Supplemental Data | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 |
| End Cash Position | $0 | $0 |
| Beginning Cash Position | $0 | $0 |
| Change In Working Capital | $43,206 | $100,650 |
| Change In Payables And Accrued Expense | $43,206 | $100,650 |
| Change In Accrued Expense | $17,992 | $76,375 |
| Change In Interest Payable | $17,992 | $76,375 |
| Change In Payable | $25,214 | $24,275 |
| Change In Account Payable | $25,214 | $24,275 |
| Other Non Cash Items | $20,315,668 | $40,342 |
| Gain Loss On Investment Securities | $-558,114 | $1,003,064 |
| Net Income From Continuing Operations | $-19,800,760 | $6,824,004 |
Fetched: 2026-02-02